Cal-Mag 2001
Natural health product licensed in Canada
- Licence holder
- Clear Medicine
- NPN or DIN-HM
- 80042722
- Status
- Inactive licence
- Licence date
- 7 June 2013
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bore Source : Citrate de bore | 1 mg | Not calculated |
| Calcium Source : Citrate de calcium | 250 mg | 750,000 µg |
| Calcium Source : Ascorbate de calcium | 250 mg | 750,000 µg |
| Calcium Source : Carbonate de calcium | 250 mg | 750,000 µg |
Non-medicinal ingredients
Silice, Stéarate de magnésium, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Vitamin and mineral supplement for the maintenance of good health. Provides glutamic acid, a non-essential amino acid involved in protein synthesis. Helps in the development and maintenance of bones. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Take a few hours before or after taking other medications. Consult a health care practitioner prior to use if you have been diagnosed with estrogen-dependent cancer.
- Contre-indications
Do not use this product if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80042722
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.